Biochemical Markers of Bone Turnover in Diabetes Patients--a Meta-analysis, and a Methodological Study on the Effects of Glucose on Bone Markers

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2014 Mar 29

PMID 24676844

Citations 82

Authors

J Starup-Linde

S A Eriksen

S Lykkeboe

A Handberg

P Vestergaard

Affiliations

Soon will be listed here.

Abstract

Unlabelled: This study examined whether markers of bone turnover differ between individuals with and without diabetes. Bone markers showed heterogeneity between studies and were discrepant for markers of bone creation and markers of bone degradation. Bone markers may be of lesser value in diabetes due to heterogeneity.

Introduction: The aim of this meta-analysis was to compare existing literature regarding changes in bone markers among diabetics compared to healthy controls. To exclude that blood glucose levels among diabetes patients could influence the assays used for determining bone turnover markers, a methodological study was performed.

Methods: Medline at Pubmed Embase, Cinahl, Svemed+, Cochrane library, and Bibliotek.dk was searched in August 2012. The studies should examine biochemical bone turnover among diabetes patients in comparison to controls in an observational design. In the methodological study, fasting blood samples were drawn from two individuals. Glucose was added to the blood samples in different concentrations and OC, CTX, and procollagen type 1 amino terminal propeptide were measured after 0, 1, 2, and 3 h.

Results: Twenty-two papers fulfilled the criteria for the meta-analysis. From the pooled data in the meta-analysis, the bone markers osteocalcin (OC) (-1.15 ng/ml [-1.78,-0.52]) and C-terminal cross-linked telopeptide (CTX) (-0.14 ng/ml [-0.22, -0.05]) were significantly lower among diabetes patients than non-diabetes patients, however other markers did not differ. All markers displayed very high heterogeneity by I2 statistics. In the methodological study, the addition of glucose did not significantly change the bone markers neither by level of glucose nor with increasing incubation time.

Conclusion: The dissociative pattern of biochemical bone markers of bone formation and bone resorption present in diabetes patients is thus not caused by glucose per se but may be modulated by unknown factors associated with diabetes mellitus.

Citing Articles

Bone Mineral Density is Negatively Associated with Risk of All-Cause and Cardiovascular Mortality among Adults with Type 2 Diabetes Mellitus: A Cross-sectional Study of the NHANES 2005-2010, 2013-2014.

Li H, Wang B, Xu D, Zhang J, Wang C Rev Cardiovasc Med. 2025; 25(12):434.

PMID: 39742238 PMC: 11683720. DOI: 10.31083/j.rcm2512434.

Assessment of fracture risk in diabetic patients.

Wang Z, Zhang M, Jia D J Diabetes Metab Disord. 2024; 23(2):1653-1663.

PMID: 39610523 PMC: 11599524. DOI: 10.1007/s40200-024-01474-8.

Insulin resistance, bone health, and fracture risk.

Armutcu F, McCloskey E Osteoporos Int. 2024; 35(11):1909-1917.

PMID: 39264439 DOI: 10.1007/s00198-024-07227-w.

Bone Fragility in Diabetes and its Management: A Narrative Review.

Leungsuwan D, Chandran M Drugs. 2024; 84(9):1111-1134.

PMID: 39103693 DOI: 10.1007/s40265-024-02078-5.

Bone Health in Patients With Type 2 Diabetes.

Forner P, Sheu A J Endocr Soc. 2024; 8(7):bvae112.

PMID: 38887632 PMC: 11181004. DOI: 10.1210/jendso/bvae112.

References

Szulc P, Delmas P . Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int. 2008; 19(12):1683-704. DOI: 10.1007/s00198-008-0660-9. View

Achemlal L, Tellal S, Rkiouak F, Nouijai A, Bezza A, Derouiche E . Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol. 2005; 24(5):493-6. DOI: 10.1007/s10067-004-1070-9. View

Whitham K . External quality assessment of bone metabolism marker assays. initial experiences in a UK NEQAS programme. Clin Chem Lab Med. 2001; 38(11):1121-4. DOI: 10.1515/CCLM.2000.168. View

Dayem S, El-Shehaby A, Abd El Gafar A, Fawzy A, Salama H . Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients. Scand J Clin Lab Invest. 2011; 71(5):387-93. DOI: 10.3109/00365513.2011.573574. View

Neumann T, Samann A, Lodes S, Kastner B, Franke S, Kiehntopf M . Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes. Diabet Med. 2011; 28(7):872-5. DOI: 10.1111/j.1464-5491.2011.03286.x. View

Vestergaard P, Rejnmark L, Mosekilde L . Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int. 2008; 84(1):45-55. DOI: 10.1007/s00223-008-9195-5. View

Galluzzi F, Stagi S, Salti R, Toni S, Piscitelli E, Simonini G . Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. Eur J Endocrinol. 2005; 153(6):879-85. DOI: 10.1530/eje.1.02052. View

Raskin P, Stevenson M, Barilla D, Pak C . The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin Endocrinol (Oxf). 1978; 9(4):329-35. DOI: 10.1111/j.1365-2265.1978.tb02218.x. View

Orwoll E, Deftos L . Serum osteocalcin (BGP) levels in normal men: a longitudinal evaluation reveals an age-associated increase. J Bone Miner Res. 1990; 5(3):259-62. DOI: 10.1002/jbmr.5650050309. View

10.

Hamada Y, Fujii H, Fukagawa M . Role of oxidative stress in diabetic bone disorder. Bone. 2009; 45 Suppl 1:S35-8. DOI: 10.1016/j.bone.2009.02.004. View

11.

Garnero P . Bone markers in osteoporosis. Curr Osteoporos Rep. 2009; 7(3):84-90. DOI: 10.1007/s11914-009-0014-3. View

12.

Hampson G, Evans C, Petitt R, Evans W, Woodhead S, Peters J . Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia. 1998; 41(11):1314-20. DOI: 10.1007/s001250051071. View

13.

Gerdhem P, Isaksson A, Akesson K, Obrant K . Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int. 2005; 16(12):1506-12. DOI: 10.1007/s00198-005-1877-5. View

14.

Vestergaard P . Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. 2006; 18(4):427-44. DOI: 10.1007/s00198-006-0253-4. View

15.

Herrmann M, Seibel M, Seibel M . The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta. 2008; 393(2):57-75. DOI: 10.1016/j.cca.2008.03.020. View

16.

Christensen J, Svendsen O . Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus. Osteoporos Int. 2000; 10(4):307-11. DOI: 10.1007/s001980050232. View

17.

Mastrandrea L, Wactawski-Wende J, Donahue R, Hovey K, Clark A, Quattrin T . Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care. 2008; 31(9):1729-35. PMC: 2518333. DOI: 10.2337/dc07-2426. View

18.

Manolagas S, Almeida M . Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol Endocrinol. 2007; 21(11):2605-14. DOI: 10.1210/me.2007-0259. View

19.

Delmas P . What do we know about biochemical bone markers?. Baillieres Clin Obstet Gynaecol. 1991; 5(4):817-30. DOI: 10.1016/s0950-3552(05)80289-5. View

20.

Bhattoa H, Onyeka U, Kalina E, Balogh A, Paragh G, Antal-Szalmas P . Bone metabolism and the 10-year probability of hip fracture and a major osteoporotic fracture using the country-specific FRAX algorithm in men over 50 years of age with type 2 diabetes mellitus: a case-control study. Clin Rheumatol. 2013; 32(8):1161-7. DOI: 10.1007/s10067-013-2254-y. View